Retraction

Xuebijing injection alleviates liver injury in patients with hepatocellular carcinoma by inhibiting inflammatory response after transarterial chemoembolization

Paper Information

Record ID:
37246
Publication Date:
August 31, 2021
Retraction Date:
December 31, 2021 (3.9 years years ago)
Article Type:
Publisher:
Pharmacotherapy Group
Open Access:
Yes
PubMed ID:
Not indexed in PubMed
Retraction PubMed ID:
Not indexed in PubMed

Retraction Details

Nature of Retraction:

Retraction

Retraction Notice:
10.4314/tjpr.v20i12.31

Citations (1)

1
Total Citations
0
Post-Retraction
0
Pre-Retraction
0
Same Day
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Quick Stats
Total Citations: 1
Years Since Retraction: 3.9 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
Prognostic Comparison between cTACE and H101-TACE in Unrese…
Applied Bionics and Biomechanics • 8 citations
Application Effect of Somatostatin Combined with Transnasal…
Computational Intelligence and Neuroscience • 7 citations
Effects of the Ultrasound-Guided Stellate Ganglion Block on…
Computational Intelligence and Neuroscience • 9 citations
Analysis of Efficacy, Safety, and Prognostic Factors of mFO…
Evidence-Based Complementary and Alternative Medicine • 9 citations